Empowering preventive health
Build a Culture of
Exceptional Care
Enhance employee wellbeing through Clinical-Grade Whole Genome Sequencing.
A modern health benefit that identifies hereditary conditions and ensures medication safety.
Join responsible organisations prioritizing precision health.
Responsibility over Novelty

Workforce Stability
Identify chronic conditions early to prevent long-term absenteeism and health-related workspace disruption.

Clinical-Grade Benefit
Offer employees professional genetic screening that identifies hereditary conditions and guides medication safety.

Informed Health Decisions
Equip employees with credible genetic information that supports informed discussions with their doctors and healthcare professionals.

Leadership Resilience
Ensure organisational stability by supporting the long-term health and wellness of your executive teams.
Informed Health Decisions
Equip employees with credible genetic information that supports informed discussions with their doctors and healthcare professionals.
Organisational Impact
See how clinical-grade genomics protects key talent and stabilises organisational health.

SUCESSION PLANNING
"Harsh (CTO) lost his brother to a genetic heart condition. Screening identified he had the same variant. Regular cardiac MRIs and preventive medication ensured that what took his brother won't take him off-guard."
Case: Senior Leadership Resilience
CTO, TECH GIANT | BENGALURU

COST MANAGEMENT
"Sanjay (CFO) had a family history of heart disease. Testing revealed condition genes AND poor response to standard statins. His doctor chose an alternative his genetics favoured—avoiding costly trial-and-error treatments."
Case: Optimised Health Claims
CFO, LOGISTICS | DELHI

BENEFIT ENQUIRY
"Pooja, a remote employee, had limited access to specialists. The corporate programme's tele-counselling explained her carrier status for a rare condition—crucial info before starting her family, provided by her employer."
Case: Remote Talent Inclusion
CUSTOMER SUCCESS | INDORE
Disclaimer: These narratives are inspired by real common clinical scenarios, based on documented applications of genetic testing. Names, professions, and identifying details are fictional composites created for educational purposes.
Responsible, Not Novelty
Precision health is backed by rigorous clinical and economic evidence. Our programme is designed for long-term clinical utility, not lifestyle traits.

4.33 %
Productivity Impact
Health-related absenteeism accounts for significant loss in GDP—preventive screening mitigates this condition.

90%
Medication Response
A vast majority carry genetic variants that influence how common medications are processed.

30%
ADR Reduction
Reduction in adverse drug reactions (ADRs) when clinical decisions are guided by genetic testing.

1 in 22
Family Condition
Couples identified as at-condition for serious inherited conditions—vital for long-term health planning.

67.6%
Workforce Continuity
Employment stability is significantly impacted by rare genetic disorders; early awareness reduces hardship.

9L+
India Births/Year
Annual infants born with detectable inherited conditions—underlining the role of carrier screening.
CLINICAL DATA SOURCES: PEER-REVIEWED GENOMICS & HEALTH ECONOMICS
*DISCLAIMER: This genetic screening programme provides condition insights and is not a diagnostic test. Results should be interpreted in consultation with qualified healthcare professionals. Statistics are derived from global and regional clinical research studies. Genetic information should be used as part of a comprehensive health management plan.
Hospitality-Driven Clinical Excellence
Karkinos operates world-class sequencing facilities designed to provide the highest accuracy and reliability for corporate health programs.

Genomics Infrastructure
State-of-the-art labs featuring 5 NovaSeq 6000 Platforms for high-throughput Whole Genome Sequencing.

Leading with India's first long-range sequencer: PacBio Revio
120k+
Sq ft. Global Standard Labs
30%
India's Sequencing Capacity
YOUR DATA. YOUR CONTROL.
Privacy-First, Clinical-Core
Genetic information is deeply personal. We treat data with the highest medical and privacy protocols, ensuring ownership remains entirely with the individual.

Data Confidentiality
Individual genetic results are strictly confidential. Employers do not receive personal health data.

Secure Handling
Samples are processed using anonymised identifiers. We never sell your genetic profile to third parties.

Voluntary Choice
Participation is completely voluntary with informed consent at the core of the experience.
Informed Health Decisions
Equip employees with credible genetic information that supports informed discussions with their doctors and healthcare professionals.

EMAIL US
genetictest@karkinos.in

EXPERT HELPLINE
+91 8591968377
Please fill the below requested information
YOUR PRIVACY IS PARAMOUNT. BY SUBMITTING, YOU AGREE TO OUR DATA POLICIES.

